CIAM
SNDX icon

Caitong International Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Caitong International Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05K Sell
48
-33,149
-100% -$689K ﹤0.01% 1532
2026
Q1 		$775K Buy
+33,197
New +$721K 0.14% 147
2025
Q4 		– Sell
-47
Closed -$723 – 2335
2025
Q3 		$723 Sell
47
-1,230
-96% -$16.1K ﹤0.01% 1509
2025
Q2 		$12K Buy
1,277
+1,068
+511% +$11.8K 0.01% 658
2025
Q1 		$2.57K Sell
209
-8,553
-98% -$121K ﹤0.01% 1248
2024
Q4 		$116K Buy
+8,762
New +$150K 0.11% 201

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Caitong International Asset Management's SNDX Position: Q2 2026 in Review

Caitong International Asset Management reduced its Syndax Pharmaceuticals (SNDX) stake by 100% in Q2 2026, selling an estimated $689K and leaving 48 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1532.

Caitong International Asset Management first reported a position in SNDX in Q4 2024 and has held it in 6 quarters since. The position peaked at $775K in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Caitong International Asset Management held 48 shares of Syndax Pharmaceuticals worth $1.05K as of Q2 2026.
  • Caitong International Asset Management sold 33,149 Syndax Pharmaceuticals shares in Q2 2026, an estimated $689K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1532 holding.
  • Caitong International Asset Management first reported a position in Syndax Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Caitong International Asset Management's Syndax Pharmaceuticals position peaked at $775K in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.